About Molecraft
Molecraft is a Chemicals & Materials company based in Hyderabad (India). It develops and produces APIs, intermediates, metabolites, and impurities for industries. It operates on a B2B model. Its Indian entity Molecraft Life Sciences Private Limited reported revenue of ₹30.3 Lakh. Its focus areas include Chemicals and Pharmaceuticals, Chemical Manufacturing, API Production and Intermediates and Metabolites. Similar companies include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent and 4 more; 4 of its 9 listed similar companies have raised funding.
Company details
Molecraft operates with a B2B model, focusing on chemicals and pharmaceuticals, chemical manufacturing, api production, and intermediates and metabolites. Develops and produces APIs, intermediates, metabolites, and impurities for industries. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Hyderabad, India
- SectorsChemicals & Materials
- Website molecraft.com
- Legal Name Molecraft Life Sciences Private Limited
- Date of Incorporation 10 Aug, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹30.3 Lakh
FY 2024 · -8% YoY
- Net Profit₹15,747
FY 2024 · 1% margin
- EBITDA₹3.7 Lakh
FY 2024 · 12% margin
Associated legal entities of Molecraft
Molecraft operates through Molecraft Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Molecraft Life Sciences Private Limited CIN U24119TG2011PTC075914 | Active | 10 Aug 2011 | Hyderabad, Telangana | ₹0.3 Cr | – | 3 | View details |
Board of directors of Molecraft Life Sciences Private Limited (Molecraft)
Molecraft Life Sciences Private Limited is the primary company behind Molecraft. The board of Molecraft Life Sciences Private Limited currently have 3 directors; the longest-serving is Lakshmi Bhanu Pedapati, appointed in 2011.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Lakshmi Bhanu Pedapati DIN 02908328 | Director | 10 Aug 2011 | 15 yrs 2 mo | Molecraft Life Sciences Private Limited |
| Venkata Ramanamurthy Pedapati DIN 02413597 | Director | 10 Aug 2011 | 15 yrs 2 mo | Molecraft Life Sciences Private Limited |
| Lalitha Aishwarya Pedapati DIN 03570644 | Director | 10 Aug 2011 | 15 yrs 2 mo | Molecraft Life Sciences Private Limited |
Financials of Molecraft
Figures of Molecraft Life Sciences Private Limited, the primary company behind Molecraft, for FY 2024. Revenue was ₹30.3 Lakh (-8% year on year). Net profit was ₹15,747 (1% margin). EBITDA was ₹3.7 Lakh (12% margin). Revenue has grown at a compounded annual rate of -4% over three years and -34% over five years.
- ₹30.3 LakhRevenue · FY 2024 · -8% YoY
- ₹15,747Net profit · 1% margin
- ₹3.7 LakhEBITDA · 12% margin
- ₹1 LakhPaid-up capital
- -4%Revenue CAGR, 3 years
- -34%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Molecraft Life Sciences Private Limited are on its company page.
Detailed financial statements for Molecraft
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Molecraft
Molecraft has 9 listed similar companies in our database, 4 of them funded. They include Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| provepharm.com | 1998 | Marseille, France | $145.93M | – | APIs and drug products are developed and valorized in pharmaceuticals. | |
| biostar-pharm.com | 2002 | Beijing, China | $135.23M | – | APIs, intermediates, and biochemical reagents are developed and manufactured. | |
| sequent.in | 2002 | Bengaluru, India | – | – | APIs are developed and manufactured for therapeutic areas. | |
| sterlingpharmasolutions.com | 2016 | Dudley, United Kingdom | – | 560 | Contract development, manufacturing, and analytical services for APIs are offered. | |
| snapdragonchemistry.com | 2014 | Cambridge, United States | – | 43 | Drug discovery and development service provider | |
| jubilantpharma.com | 1978 | Noida, India | – | – | Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. | |
| hikal.com | 1988 | Mumbai, India | – | 355 | APIs and intermediates are produced via custom synthesis and research. |
Detailed similar companies of Molecraft
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Petrochemicals & Derivatives
10 companies that operate in the same segment as Molecraft (Petrochemicals & Derivatives), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Aramco is recognized as a leading producer of energy and chemicals globally. | 1993 | Dhahran, Eastern Province, Saudi Arabia | – | – | – | |
Petrochemicals, chemicals, and thermoplastic resins are produced for businesses. | 2002 | Sao Paulo, Brazil | – | USD 12.91 B | 8,380 | |
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide. | 1992 | Mumbai, Maharashtra, India | – | USD 479.49 M | 976 | |
Lubricants, additives, vehicle care, and repair liquids are manufactured. | 1957 | Ulm, Baden-wurttemberg, Germany | – | – | – | |
PET resins, PET products, and wool yarn are manufactured. | 1994 | Bangkok, Thailand | – | USD 14.12 B | 175 | |
Polybutene-based petrochemicals are produced by the company. | 1990 | Chennai, Tamil Nadu, India | – | USD 62.67 M | 194 | |
Petrochemicals and derivatives are manufactured in Thailand. | 2011 | Rayong, Thailand | – | USD 15.39 B | – | |
Petrochemical products are manufactured and supplied by SCGC. | 1994 | Bangkok, Thailand | – | USD 35.91 M | – | |
Petrochemical products and materials are supplied globally for key industries. | 1957 | Tokyo, Tokyo, Japan | – | USD 750.07 K | – | |
Refined fuels, polymers, and monomers are produced for industrial applications. | 2005 | Rabigh, Makkah Region, Saudi Arabia | – | – | 2,944 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Molecraft
Molecraft is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
The primary company behind Molecraft, Molecraft Life Sciences Private Limited, reported revenue of ₹30.3 Lakh for FY 2024, down 8% year on year.
Molecraft operates with a B2B model, focusing on chemicals and pharmaceuticals, chemical manufacturing, api production, and intermediates and metabolites. Develops and produces APIs, intermediates, metabolites, and impurities for industries. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Molecraft's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Molecraft operates through Molecraft Life Sciences Private Limited.
The legal entities of Molecraft currently have 3 directors, including Lakshmi Bhanu Pedapati, Venkata Ramanamurthy Pedapati, Lalitha Aishwarya Pedapati.